Skip to content
The Nexus
DossierENTITY

Hale Family Center for Pancreatic Cancer Research

Coverage of Hale Family Center for Pancreatic Cancer Research in the Nexus archive.

Earliest in view: May 18 · 11:00 UTCMost recent: May 18 · 11:00 UTC
Co-mentioned in this coverage
Daraxonrasibtopic1Dana-Farber Cancer Instituteorganization1Brian Wolpinperson1The New England Journal of Medicineorganization1
Recent coverage
  • HEALTHMay 18 · 11:00 UTCFOX NEWS
    New pancreatic cancer pill could reshape treatment as early trial results stun researchers

    A new pancreatic cancer pill called Daraxonrasib has shown promise in early testing, with about 30% of patients seeing a positive response and 90% having their cancer either shrink or stop getting worse. The pill is designed to block multiple active cancer signals that help tumor cells grow. The clinical trial was led by the Dana-Farber Cancer Institute.